Advertisement

Subthalamic Nucleus Deep Brain Stimulation with Microelectrode Recording Using a Frame

  • Andres L. Maldonado-Naranjo
  • Andre G. Machado
  • Michal Gostkowski
  • Hubert H. Fernandez
  • Sean J. Nagel
Chapter

Abstract

Potential surgical candidates with Parkinson’s disease (PD) are first preselected by a movement disorders neurologist, subsequently seen by multiple specialists, and ultimately rendered as surgical candidates through a series of discussions by each member of the multidisciplinary team during dedicated patient management conferences. Patients considered for a full presurgical evaluation are those with a clear diagnosis of progressive idiopathic PD and an adequate response to levodopa. The current state of surgery for movement disorders, particularly DBS, is in constant change. New technologies, in particular, neuronavigation, frames, and leads, fill up the neurosurgeon’s armamentarium with several options when providing care for these patients. This chapter provides a description of the indications, preoperative evaluation, targeting, and an overview of the technical nuances of DBS for PD, along with its complications.

Keywords

Deep brain stimulation Subthalamic nucleus Parkinson’s disease Frame 

Bibliography

  1. 1.
    Schiefer TK, Matsumoto JY, Lee KH. Moving forward: advances in the treatment of movement disorders with deep brain stimulation. Front Integr Neurosci. 2011;5:69.CrossRefGoogle Scholar
  2. 2.
    Bucy PC. Cortical extirpation in the treatment of involuntary movements. Am J Surg. 1948 Jan;75(1):257–63.CrossRefGoogle Scholar
  3. 3.
    Putnam T. Relief from unilateral paralysis agitans by section of the lateral pyramidal tract. Arch Neurol Psychiatr. 1938;40:1049.Google Scholar
  4. 4.
    Cooper IS. Anterior chorodial artery ligation for involuntary movements. Science. 1953;118(3059):193.CrossRefGoogle Scholar
  5. 5.
    Cooper IS. An investigation of neurosurgical alleviation of parkinsonism, chorea, athetosis and dystonia. Ann Intern Med. 1956;45(3):381–92.CrossRefGoogle Scholar
  6. 6.
    Spiegel EA, Wycis HT, Marks M, Lee AJ. Stereotaxic apparatus for operations on the human brain. Science. 1947;106(2754):349–50.CrossRefGoogle Scholar
  7. 7.
    Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol. 1987;50(1–6):344–6.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Benabid AL, Pollak P, Gervason C, Hoffmann D, Gao DM, Hommel M, Perret JE, de Rougemont J. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet. 1991;337(8738):403–6.CrossRefGoogle Scholar
  9. 9.
    Benabid AL, Pollak P, Gross C, Hoffmann D, Benazzouz A, Gao DM, et al. Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact Funct Neurosurg. 1994;62(1–4):76–84.CrossRefGoogle Scholar
  10. 10.
    Perestelo-Perez L, Rivero-Santana A, Perez-Ramos J, Serrano-Perez P, Panetta J, Hilarion P. Deep brain stimulation in Parkinson's disease: meta-analysis of randomized controlled trials. J Neurol. 2014 Nov;261(11):2051–60.CrossRefGoogle Scholar
  11. 11.
    Abboud H, Floden D, Thompson NR, Genc G, Oravivattanakul S, Alsallom F, et al. Impact of mild cognitive impairment on outcome following deep brain stimulation surgery for Parkinson's disease. Parkinsonism Relat Disord. 2015 Mar;21(3):249–53.CrossRefGoogle Scholar
  12. 12.
    Weaver F, Follett K, Hur K, Ippolito D, Stern M. Deep brain stimulation in Parkinson disease: a metaanalysis of patient outcomes. J Neurosurg. 2005 Dec;103(6):956–67.CrossRefGoogle Scholar
  13. 13.
    Pollak P. Deep brain stimulation for Parkinson's disease - patient selection. Handb Clin Neurol. 2013;116:97–105.CrossRefGoogle Scholar
  14. 14.
    Saint-Cyr JA, Trepanier LL, Kumar R, Lozano AM, Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain. 2000;123(Pt 10):2091–108.CrossRefGoogle Scholar
  15. 15.
    Mogilner AY, Sterio D, Rezai AR, Zonenshayn M, Kelly PJ, Beric A. Subthalamic nucleus stimulation in patients with a prior pallidotomy. J Neurosurg. 2002 Apr;96(4):660–5.CrossRefGoogle Scholar
  16. 16.
    Beric A, Kelly PJ, Rezai A, Sterio D, Mogilner A, Zonenshayn M, et al. Complications of deep brain stimulation surgery. Stereotact Funct Neurosurg. 2001;77(1–4):73–8.CrossRefGoogle Scholar
  17. 17.
    Hariz MI. Complications of deep brain stimulation surgery. Mov Disord. 2002;17(Suppl 3):S162–6.CrossRefGoogle Scholar
  18. 18.
    Umemura A, Jaggi JL, Hurtig HI, Siderowf AD, Colcher A, Stern MB, et al. Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. J Neurosurg. 2003 Apr;98(4):779–84.CrossRefGoogle Scholar
  19. 19.
    Sharan A, Rezai AR, Nyenhuis JA, Hrdlicka G, Tkach J, Baker K, et al. MR safety in patients with implanted deep brain stimulation systems (DBS). Acta Neurochir Suppl. 2003;87:141–5.PubMedGoogle Scholar
  20. 20.
    Rezai AR, Phillips M, Baker KB, Sharan AD, Nyenhuis J, Tkach J, et al. Neurostimulation system used for deep brain stimulation (DBS): MR safety issues and implications of failing to follow safety recommendations. Investig Radiol. 2004 May;39(5):300–3.CrossRefGoogle Scholar
  21. 21.
    Baker KB, Tkach JA, Nyenhuis JA, Phillips M, Shellock FG, Gonzalez-Martinez J, et al. Evaluation of specific absorption rate as a dosimeter of MRI-related implant heating. J Magn Reson Imaging. 2004 Aug;20(2):315–20.CrossRefGoogle Scholar
  22. 22.
    Duchin Y, Abosch A, Yacoub E, Sapiro G, Harel N. Feasibility of using ultra-high field (7 T) MRI for clinical surgical targeting. PLoS One. 2012;7(5):e37328.CrossRefGoogle Scholar
  23. 23.
    Andrade-Souza YM, Schwalb JM, Hamani C, Eltahawy H, Hoque T, Saint-Cyr J, et al. Comparison of three methods of targeting the subthalamic nucleus for chronic stimulation in Parkinson's disease. Neurosurgery. 2005;56(2 Suppl):360,8. discussion 360-8Google Scholar
  24. 24.
    Laxton AW, Tang-Wai DF, McAndrews MP, Zumsteg D, Wennberg R, Keren R, et al. A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease. Ann Neurol. 2010;68(4):521–34.CrossRefGoogle Scholar
  25. 25.
    Gologorsky Y, Ben-Haim S, Moshier EL, Godbold J, Tagliati M, Weisz D, Alterman RL. Transgressing the ventricular wall during subthalamic deep brain stimulation surgery for Parkinson disease increases the risk of adverse neurological sequelae. Neurosurgery. 2011;69(2):294–9. discussion 299-300CrossRefGoogle Scholar
  26. 26.
    Coenen VA, Gielen FL, Castro-Prado F, Abdel Rahman A, Honey CR. Noradrenergic modulation of subthalamic nucleus activity in human: metoprolol reduces spiking activity in microelectrode recordings during deep brain stimulation surgery for Parkinson's disease. Acta Neurochir. 2008;150(8):757,62. discussion 762CrossRefGoogle Scholar
  27. 27.
    Konrad PE, Neimat JS, Yu H, Kao CC, Remple MS, D'Haese PF, et al. Customized, miniature rapid-prototype stereotactic frames for use in deep brain stimulator surgery: initial clinical methodology and experience from 263 patients from 2002 to 2008. Stereotact Funct Neurosurg. 2011;89(1):34–41.CrossRefGoogle Scholar
  28. 28.
    Hutchison WD, Allan RJ, Opitz H, Levy R, Dostrovsky JO, Lang AE, et al. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol. 1998;44(4):622–8.CrossRefGoogle Scholar
  29. 29.
    Sterio D, Zonenshayn M, Mogilner AY, Rezai AR, Kiprovski K, Kelly PJ, et al. Neurophysiological refinement of subthalamic nucleus targeting. Neurosurgery. 2002;50(1):58–67; discussion 67-9.PubMedPubMedCentralGoogle Scholar
  30. 30.
    Benazzouz A, Breit S, Koudsie A, Pollak P, Krack P, Benabid AL. Intraoperative microrecordings of the subthalamic nucleus in Parkinson's disease. Mov Disord. 2002;17(Suppl 3):S145–9.CrossRefGoogle Scholar
  31. 31.
    Rodriguez-Oroz MC, Rodriguez M, Guridi J, Mewes K, Chockkman V, Vitek J, et al. The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. Brain. 2001 Sep;124(Pt 9):1777–90.CrossRefGoogle Scholar
  32. 32.
    Peppe A, Pierantozzi M, Bassi A, Altibrandi MG, Brusa L, Stefani A, et al. Stimulation of the subthalamic nucleus compared with the globus pallidus internus in patients with Parkinson disease. J Neurosurg. 2004 Aug;101(2):195–200.CrossRefGoogle Scholar
  33. 33.
    Bejjani BP, Dormont D, Pidoux B, Yelnik J, Damier P, Arnulf I, et al. Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg. 2000 Apr;92(4):615–25.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Andres L. Maldonado-Naranjo
    • 1
  • Andre G. Machado
    • 1
    • 2
  • Michal Gostkowski
    • 2
    • 3
  • Hubert H. Fernandez
    • 2
    • 3
  • Sean J. Nagel
    • 1
    • 2
  1. 1.Department of NeurosurgeryCleveland Clinic, Neurologic InstituteClevelandUSA
  2. 2.Cleveland Clinic, Neurologic Institute, Center for Neurological RestorationClevelandUSA
  3. 3.Department of NeurologyCleveland Clinic, Neurologic InstituteClevelandUSA

Personalised recommendations